Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • autism (2)
  • case control studies (1)
  • child (1)
  • childhood (2)
  • cohorts (2)
  • cord blood (2)
  • CYP2E1 (2)
  • female (1)
  • fetal blood (1)
  • humans (1)
  • infant newborn (1)
  • newborn (3)
  • OR2L13 (2)
  • pregnancy (4)
  • young adult (1)
  • Sizes of these terms reflect their relevance to your search.

    Maternal gestational diabetes mellitus (GDM) has been associated with adverse outcomes in the offspring. Growing evidence suggests that the epigenome may play a role, but most previous studies have been small and adjusted for few covariates. The current study meta-analyzed the association between maternal GDM and cord blood DNA methylation in the Pregnancy and Childhood Epigenetics (PACE) consortium. Seven pregnancy cohorts (3,677 mother-newborn pairs [317 with GDM]) contributed results from epigenome-wide association studies, using DNA methylation data acquired by the Infinium HumanMethylation450 BeadChip array. Associations between GDM and DNA methylation were examined using robust linear regression, with adjustment for potential confounders. Fixed-effects meta-analyses were performed using METAL. Differentially methylated regions (DMRs) were identified by taking the intersection of results obtained using two regional approaches: comb-p and DMRcate. Two DMRs were identified by both comb-p and DMRcate. Both regions were hypomethylated in newborns exposed to GDM in utero compared with control subjects. One DMR (chr 1: 248100345-248100614) was located in the OR2L13 promoter, and the other (chr 10: 135341870-135342620) was located in the gene body of CYP2E1. Individual CpG analyses did not reveal any differentially methylated loci based on a false discovery rate-adjusted P value threshold of 0.05. Maternal GDM was associated with lower cord blood methylation levels within two regions, including the promoter of OR2L13, a gene associated with autism spectrum disorder, and the gene body of CYP2E1, which is upregulated in type 1 and type 2 diabetes. Future studies are needed to understand whether these associations are causal and possible health consequences. © 2019 by the American Diabetes Association.

    Citation

    Caitlin G Howe, Bianca Cox, Ruby Fore, James Jungius, Tuomas Kvist, Samantha Lent, Harriet E Miles, Lucas A Salas, Sheryl Rifas-Shiman, Anne P Starling, Paul Yousefi, Christine Ladd-Acosta, Andrea Baccarelli, Elisabeth B Binder, Vaia Lida Chatzi, Darina Czamara, Dana Dabelea, Dawn L DeMeo, Akram Ghantous, Zdenko Herceg, Eero Kajantie, Jari M T Lahti, Debbie A Lawlor, Augusto Litonjua, Tim S Nawrot, Ellen A Nohr, Emily Oken, Costanza Pizzi, Michelle Plusquin, Katri Räikkönen, Caroline L Relton, Gemma C Sharp, Thorkild I A Sørensen, Jordi Sunyer, Martine Vrijheid, Weiming Zhang, Marie-France Hivert, Carrie V Breton. Maternal Gestational Diabetes Mellitus and Newborn DNA Methylation: Findings From the Pregnancy and Childhood Epigenetics Consortium. Diabetes care. 2020 Jan;43(1):98-105

    Expand section icon Mesh Tags


    PMID: 31601636

    View Full Text